Comment on Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain - Response

被引：0
|
作者：
Ballantyne, Jane C. [1 ]
LaForge, L. Stephen [1 ]
机构：
[1] Massachusetts Gen Hosp, MGH Pain Ctr, Dept Anesthesia & Crit Care, Andover, MA 01810 USA
来源：
PAIN | 2007年 / 132卷 / 1-2期
关键词：
D O I：
10.1016/j.pain.2007.08.019
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [41] Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic
    Perry, Allison
    Wheeler-Martin, Katherine
    Hasin, Deborah S.
    Terlizzi, Kelly
    Mannes, Zachary L.
    Jent, Victoria
    Townsend, Tarlise N.
    Ii, John R. Pamplin
    Crystal, Stephen
    Martins, Silvia S.
    Cerd, Magdalena
    Krawczyk, Noa
    DRUG AND ALCOHOL DEPENDENCE, 2023, 253
  • [42] Nausea and Vomiting Side Effects with Opioid Analgesics during Treatment of Chronic Pain: Mechanisms, Implications, and Management Options
    Porreca, Frank
    Ossipov, Michael H.
    PAIN MEDICINE, 2009, 10 (04) : 654 - 662
  • [43] Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment
    MacLean, R. Ross
    Ankawi, Brett
    Driscoll, Mary A.
    Gordon, Melissa A.
    Frankforter, Tami L.
    Nich, Charla
    Szollosy, Sara K.
    Loya, Jennifer M.
    Brito, Larissa
    Ribeiro, Margaridha I. P.
    Edmond, Sara N.
    Becker, William C.
    Martino, Steve
    Sofuoglu, Mehmet
    Heapy, Alicia A.
    JMIR RESEARCH PROTOCOLS, 2024, 13
  • [44] Substance misuse in patients who have comorbid chronic pain in a clinical population receiving methadone maintenance therapy for the treatment of opioid dependence
    Higgins, Cassie
    Smith, Blair H.
    Matthews, Keith
    DRUG AND ALCOHOL DEPENDENCE, 2018, 193 : 131 - 136
  • [45] CHRONIC PAIN AND DEPENDENCE CASE SERIES: A "FLYING SQUAD" APPROACH TO THE TRANSFER OF UNSTABLE PRESCRIPTION OPIOID PATIENTS TO SUPERVISED TREATMENT IN A COMMUNITY SETTING
    Hardy, Mark
    Dore, Glenys
    DRUG AND ALCOHOL REVIEW, 2010, 29 : 32 - 32
  • [46] Naldemedine Is Effective in the Treatment of Opioid-Induced Constipation in Chronic Non-Cancer Pain in Subjects With or Without Inadequate Response to Laxatives
    Tack, Jan
    Hale, Martin E.
    Krauter, Eric
    Yamada, Tadaaki
    Yokota, Takaaki
    Wild, James E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S251 - S252
  • [47] Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives
    Hale, Martin E.
    Wild, James E.
    Yamada, Tadaaki
    Yokota, Takaaki
    Tack, Jan
    Andresen, Viola
    Drewes, Asbjorn Mohr
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [48] The efficacy of buprenorphine/naloxone as a pain relief agent in patients self-identified as having comorbid chronic pain who are being treated in a general office-based opioid addiction treatment program
    Sullivan, C. R.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 : 69 - 70
  • [49] Assessment of opioid analgesics addiction in patients with non-cancerous chronic pain followed at a center for pain assessment and treatment using a substance use disorders questionnaire derived from DSM-V criteria
    Eiden, C.
    Ginies, P.
    Nogue, E.
    Damdjy, Y.
    Picot, M. C.
    Donnadieu-Rigole, H.
    Peyriere, H.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 29 - 29
  • [50] Assessment of addiction to opioid analgesics in a population of patients of chronic non-cancer pain treated at a pain assessment and treatment center (PATC), via the questionnaire on the disorders related to the use of DSM-V substances
    Eiden, C.
    Ginies, P.
    Nogue, E.
    Damdjy, Y.
    Picot, M. -C.
    Donnadieu-Rigole, H.
    Peyriere, H.
    THERAPIE, 2017, 72 (01): : 169 - 170
12345